Hypoxia Profiles Identified in Term Newborns With Cord pH <7.00
RCFHypA
1 other identifier
observational
400
1 country
1
Brief Summary
Severe neonatal acidosis is an identified risk factor for neonatal encephalopathies and severe neurological sequelae such as cerebral palsy. While intrapartum origin of such deterioration is rare (approximately 20% of adverse outcomes in term infants), screening for hypoxia that can lead to the development of severe acidosis remains inadequate. This results in both delays in diagnosis and/or intervention, and a parallel increase in obstetric interventions (cesarean sections and operative vaginal deliveries) sometimes performed with inappropriate indications, thus contributing to unnecessary maternal and neonatal comorbidities. Difficulties in analyzing fetal heart rate (FHR) patterns are identified as an independent risk factor, particularly due to significant inter- and intra-observer variability, in an examination that is nevertheless central to assessing fetal well-being during labor. An FHR analysis based on a thorough understanding of the physiology of fetal adaptation to hypoxia could allow for better recognition of situations where fetal compensation for hypoxic stress is no longer possible, when adaptive mechanisms are exhausted. Given that FHR interpretation errors are implicated in 35 to 50% of adverse neonatal outcomes (peripartum death, early neonatal death, or irreversible brain damage), the preventability of these traumatic complications for families is systematically called into question. Furthermore, recent data suggest that defining hypoxia profiles associated with tracing characteristics would allow for more accurate identification of these situations, and for improved use of intervention in a more appropriate manner in terms of time and resources, in an attempt to reduce the incidence of neonatal complications of hypoxic origin involved in the development of severe neurological sequelae.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2025
CompletedFirst Submitted
Initial submission to the registry
December 31, 2025
CompletedFirst Posted
Study publicly available on registry
January 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 14, 2026
January 12, 2026
December 1, 2025
1.3 years
December 31, 2025
December 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Apgar score
Apgar score: * 7 to 10 points: Healthy baby * 4 to 6 points: The baby needs some help (oxygen, stimulation, etc.) * 0 to 3 points: Urgent situation; the baby needs immediate care
The score is measured 1 minute and 5 minutes after birth.
Eligibility Criteria
Adult woman (≥ 18 years) with singleton pregnancy and cord arterial pH \< 7.00
You may qualify if:
- Adult woman (≥ 18 years)
- Treated at Strasbourg University Hospital between January 1, 2014, and December 31, 2024
- Singleton pregnancy
- Cord arterial pH \< 7.00
You may not qualify if:
- Gestational age \< 37 weeks
- Known congenital malformation
- Intrauterine fetal death diagnosed upon admission
- No cardiotocographic recording
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Gynécologie-Obstétrique - CHU de Strasbourg - France
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 31, 2025
First Posted
January 12, 2026
Study Start
April 4, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 14, 2026
Last Updated
January 12, 2026
Record last verified: 2025-12